You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《異動股》君聖泰(02511.HK)及聖諾(02257.HK)挫14% 科倫博泰生物(06990.HK)漲12%
恆指午後高見17,214創近四個月高,現報17,197,反覆續升104點或0.6%,總成交額745億元。 醫藥股個別發展,上周四主席156萬股持股遭券商強制出售的聖諾醫藥-B(02257.HK)連續第二天創上市新低,最低見8.75元,現報8.89元,續跌14%,成交增至250萬股。 半新股君聖泰醫藥-B(02511.HK)午後低見7.04元,再創上市新低,現報7.14元,挫近14%。宜明昂科-B(01541.HK)挫8.8%報17.98元,股價失守10天及20天線。 騰盛博藥-B(02137.HK)續跌4.9%報0.97元。開拓藥業-B(9939.HK)跌5.2%報0.92元。 藥明生物(02269.HK)、藥明康德(02359.HK)及藥明合聯(02268.HK)回吐逾1.5%-4%,後者沽壓最大報19.54元,回吐4.2%。 百濟神州(06160.HK)、翰森(03692.HK)、國藥(01099.HK)、信達生物(01801.HK)及三葉草生物-B(02197.HK)跌逾2%-3%。 然而,科倫博泰生物-B(06990.HK)高見134元,現報131.9元,反覆回升12%。金斯瑞(01548.HK)升6%報16.64元。榮昌生物(09995.HK)回升逾2%報24.55元。石藥(01093.HK)反覆續升1.6%報6.46元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account